Last Updated: June 25, 2026

Suppliers and packagers for NITROLINGUAL


✉ Email this page to a colleague

« Back to Dashboard


NITROLINGUAL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA INDEPENDENCE PHARMACEUTICALS, LLC 21724-100-41 1 BOTTLE, SPRAY in 1 CARTON (21724-100-41) / 200 SPRAY in 1 BOTTLE, SPRAY 2024-12-02
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA INDEPENDENCE PHARMACEUTICALS, LLC 21724-100-50 1 BOTTLE, SPRAY in 1 CARTON (21724-100-50) / 60 SPRAY in 1 BOTTLE, SPRAY 2024-12-02
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA AUTHORIZED GENERIC Allegis Pharmaceuticals, LLC 28595-120-49 1 BOTTLE in 1 CARTON (28595-120-49) / 60 SPRAY in 1 BOTTLE 2019-07-01
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1519-1 1 BOTTLE in 1 CARTON (51662-1519-1) / 60 SPRAY in 1 BOTTLE 2020-06-25
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1519-2 60 SPRAY in 1 BOTTLE (51662-1519-2) 2020-06-25
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1672-1 1 BOTTLE, SPRAY in 1 CARTON (51662-1672-1) / 60 SPRAY in 1 BOTTLE, SPRAY (51662-1672-2) 2024-12-02
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-241-41 1 BOTTLE, SPRAY in 1 CARTON (66993-241-41) / 200 SPRAY in 1 BOTTLE, SPRAY 2024-12-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for NITROLINGUAL

Last updated: May 30, 2026

NITROLINGUAL suppliers: Who manufactures and distributes the nitroglycerin spray and what supply-chain players matter

NITROLINGUAL (nitroglycerin, sublingual/oromucosal spray) is supplied through branded and local distribution networks rather than a widely disclosed, single global manufacturer profile in public listings. The most consistent supplier signals come from the product’s registered marketing holder per country and the commercial distribution entities on packaging and in regulator-held product records.

Who supplies NITROLINGUAL (nitroglycerin) across markets?

NITROLINGUAL is typically supplied as a packaged branded nitroglycerin oromucosal spray in national markets. Supplier identification in practice is driven by three tiers:

  1. Marketing authorization holder (MAH) / brand owner in each country (appears on local labeling and regulator records).
  2. Local distributor / wholesale license holder (routes product to pharmacies and hospitals).
  3. Manufacturing sites (identified on packaging and in regulator dossiers for each marketed strength and dosage form).

Publicly accessible information often shows the brand owner and local distributor more reliably than the exact manufacturing plant unless the site is explicitly listed in local regulatory product summaries.

What packaging details usually reveal suppliers?

For NITROLINGUAL spray products, labeling commonly includes:

  • MAH name and address
  • Manufacturer name and manufacturing site (or “packed by” entity)
  • Batch information and release/packaging location
  • National distributor entity (varies by country)

What companies are the MAH and distributors for NITROLINGUAL?

NITROLINGUAL is associated with Germane brand ownership and distribution under a Bayer-linked corporate trail in several markets, with the nitroglycerin spray sold via local MAHs and distributors depending on country-specific marketing authorizations.

However, supplier names cannot be stated accurately without tying to a specific country (and strength) because MAH and distributor identities change by jurisdiction and labeling. The supplier set also differs between:

  • prescription-only retail supply vs hospital supply
  • older product presentations vs later reformulations/pack sizes

Which manufacturing sites produce NITROLINGUAL spray?

Manufacturing for NITROLINGUAL is typically handled by a defined set of contract manufacturing sites and/or internal manufacturing within the MAH’s supply chain. Manufacturing-site identification depends on:

  • country marketing authorization dossier
  • batch labeling for that market
  • strength and pack format (spray vs other nitroglycerin presentations)

Public, regulator-level “site of manufacture” details are not uniform across countries. Without country-specific product record extraction, stating manufacturing-site suppliers would risk listing entities that are correct in one market but wrong in another.

How do NITROLINGUAL supply chains work in pharmacy and hospital channels?

In most EU-style and comparable regulated supply chains, distribution to end users works through:

  • licensed wholesalers who hold temperature-controlled logistics capabilities (nitroglycerin products are sensitive but typically have defined storage conditions rather than complex cold-chain)
  • regional distribution centers supplying pharmacies
  • tender-based hospital procurement where distributors bid under national wholesaler rules

Key supply risk points for nitroglycerin spray brands usually include:

  • contract packaging capacity constraints
  • MAH batch release bottlenecks
  • regulatory variations across packaging presentations

Does NITROLINGUAL have alternative suppliers via generics or equivalents?

Yes. Like many off-patent nitroglycerin products, NITROLINGUAL faces:

  • generic nitroglycerin sublingual/oromucosal sprays with different suppliers
  • authorized generics under different MAHs in different countries

For procurement, the practical supplier choice is driven by local equivalency:

  • same active ingredient (nitroglycerin)
  • same route (sublingual/oromucosal)
  • comparable dosing and spray pump mechanics
  • national bioequivalence and substitution rules

What supplier information matters for procurement, tenders, and sourcing?

For high-stakes sourcing decisions (pharmacy formularies, hospital tenders, wholesale procurement), the supplier-relevant fields are:

  • Regulatory MAH for the exact national product code (not the global brand name)
  • Site of manufacture and packager
  • Wholesale distribution license holder for the receiving market
  • Batch release country and labeling language
  • Stability and storage conditions per the local SmPC label
  • Availability history for last 6 to 12 months (from wholesaler fulfillment data)

How strong is supplier concentration risk for NITROLINGUAL?

Supplier concentration risk is generally moderate to high for branded presentations because:

  • dosing devices (spray pumps) and packaging are usually specialized
  • batch release and packaging are performed at a limited number of approved sites per country
  • local MAH/distributor pairs can be exclusive under national contracts

The most material risk is operational: when one approved manufacturing or packaging site is offline, national supply can tighten quickly.

Key Takeaways

  • NITROLINGUAL supply is defined by country-specific MAH/distributor and approved manufacturing/packaging sites.
  • Public “one-size-fits-all” global supplier identification is not reliable because MAH and distributor identities vary by jurisdiction.
  • For procurement and compliance, supplier qualification should be anchored to the exact national product record and the labeling batch manufacturer/packager.

FAQs

  1. Who is the manufacturer of NITROLINGUAL spray in the EU?
    Manufacturer is identified on the product label and in the local regulator dossier; it varies by country and batch packaging site.

  2. Can I buy NITROLINGUAL through multiple wholesalers?
    Yes in most markets, but the brand MAH/distributor contract can limit which wholesalers carry the exact NITROLINGUAL presentation.

  3. Are there generic equivalents to NITROLINGUAL nitroglycerin spray?
    Yes, many markets have nitroglycerin sublingual/oromucosal spray equivalents under different MAHs and suppliers.

  4. What information should hospital pharmacy teams verify on NITROLINGUAL deliveries?
    MAH, manufacturer/packager site, batch number, expiration date, storage conditions, and national regulatory labeling.

  5. What are the main supply-chain risks for nitroglycerin sprays?
    Approved-site capacity and batch release/packaging constraints, plus national distributor availability for that exact presentation.

References

  1. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (Accessed 2026-05-31).
  2. EMA. European public assessment reports and product information resources. (Accessed 2026-05-31).
  3. National regulator product databases (country-specific access points). (Accessed 2026-05-31).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.